Therefore, wortmannin should not only affect NHEJ through inhibition of DNA-PK activity in NSCLC cell lines (Sak et al, 2002), but also HR via inhibition of ATM-dependent formation of Rad51 foci. Here, PRKDC is linked to non-small cell lung carcinoma.